相关实验视频
Updated: Jan 15, 2026

07:56
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
Published on: August 18, 2010
13.9K
肺向RNA输送系统:策略和治疗应用
Shenrui Xu1,2,3, Min Li2, Tingting Wang4
1Key Laboratory of Biomacromolecules, National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100091, China.
Journal of nanobiotechnology
|January 13, 2026
概括
RNA疗法对喘和COPD等肺部疾病提供了前景. 本综述详细介绍了传递系统设计如何影响肺向和疗效,为临床转化提供了路线图.
科学领域:
- 肺部医学和药物输送科学.
背景情况:
- 肺部疾病 (喘,肺癌,慢性肺炎,纤维化) 在全球造成重大健康负担.
- RNA疗法在分子水平疾病调节方面显示出前景.
- 高效,肺特异性RNA输送是临床应用的一个主要障碍.
研究的目的:
- 整合结构-功能原理与临床翻译洞察力,用于肺部RNA输送.
- 提供对物理化学参数如何影响肺热量和治疗疗效的机制性理解.
- 确定关键障碍,并为加速肺部疾病RNA疗法的临床转化提供路线图.
主要方法:
- 对合成和生物衍生RNA载体的系统检查.
- 专注于针对肺部的输送策略:吸入,静脉注射和局部肺部输送.
- 对临床试验失败的批判性分析 (例如,ALN-RSV01,MRT-5005) 以确定翻译障碍.
主要成果:
- 输送系统的物理化学特性极大地影响了肺部的热量和疗效.
- 吸入,静脉注射和局部管理提供了不同的向机会和挑战.
- 对临床失败的分析突出了关键障碍,包括配方稳定性,免疫性和制造.
结论:
- 了解结构-功能关系是设计有效的肺RNA递送系统的关键.
- 解决配方稳定性,免疫学兼容性和可扩展的制造对于临床成功至关重要.
- 这一综述为推进肺部疾病的RNA疗法提供了一个框架,从长椅到床边.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K

